Patient Outcomes

Single Psilocybin Dose Delivers Two-Year Relief From Depression and Anxiety in Cancer Patients

More than half of cancer patients in the Phase II trial experienced sustained remission of depressive symptoms with a single dose of psilocybin, prompting researchers to launch repeat-dose studies.